The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Abstract
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on multidisciplinary international consensus. ONJ is associated with oncology-dose parenteral antiresorptive therapy of bisphosphonates (BP) and denosumab (Dmab). The incidence of ONJ is greatest in the oncology patient population (1% to 15%), where high doses of these medications are used at frequent intervals. In the osteoporosis patient population, the incidence of ONJ is estimated at 0.001% to 0.01%, marginally higher than the incidence in the general population (<0.001%). New insights into the pathophysiology of ONJ include antiresorptive effects of BPs and Dmab, effects of BPs on gamma delta T-cells and on monocyte and macrophage function, as well as the role of local bacterial infection, inflammation, and necrosis. Advances in imaging include the use of cone beam computerized tomography assessing cortical and cancellous architecture with lower radiation exposure, magnetic resonance imaging, bone scanning, and positron emission tomography, although plain films often suffice. Other risk factors for ONJ include glucocorticoid use, maxillary or mandibular bone surgery, poor oral hygiene, chronic inflammation, diabetes mellitus, ill-fitting dentures, as well as other drugs, including antiangiogenic agents. Prevention strategies for ONJ include elimination or stabilization of oral disease prior to initiation of antiresorptive agents, as well as maintenance of good oral hygiene. In those patients at high risk for the development of ONJ, including cancer patients receiving high-dose BP or Dmab therapy, consideration should be given to withholding antiresorptive therapy following extensive oral surgery until the surgical site heals with mature mucosal coverage. Management of ONJ is based on the stage of the disease, size of the lesions, and the presence of contributing drug therapy and comorbidity. Conservative therapy includes topical antibiotic oral rinses and systemic antibiotic therapy. Localized surgical debridement is indicated in advanced nonresponsive disease and has been successful. Early data have suggested enhanced osseous wound healing with teriparatide in those without contraindications for its use. Experimental therapy includes bone marrow stem cell intralesional transplantation, low-level laser therapy, local platelet-derived growth factor application, hyperbaric oxygen, and tissue grafting. © 2014 American Society for Bone and Mineral Research © 2014 American Society for Bone and Mineral Research
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Iwamoto, J., Satō, Y., Uzawa, M., Takeda, T., & Matsumoto, H. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.03.033 · Cited by 22
RetractedDenosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Self-citationMarx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Oral and maxillofacial pathology
(1996) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(96)90514-5 · Cited by 2,967
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.031 · Cited by 2,905
Self-citationOsteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Self-citationZoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003 · cited 2×
“BPs for the treatment of ONJ ranges from 0 to 90 per 100,000 patient-years.((58,59,65,67,68)) Last, the incidence of ONJ in patients who are prescribed Dmab ranges from 0 to 30.”
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Self-citationKhosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Self-citationMarx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.010 · Cited by 1,648
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Ruggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.009 · Cited by 1,328
Self-citationHenry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8670 · Cited by 1,149
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
(2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.11.003 · Cited by 837
Smith, M. R., Saad, F., Coleman, R., Shore, N., Fizazi, K., Tombal, B., Miller, K., Sieber, P., Karsh, L., Damião, R., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61226-9 · Cited by 797
Marx, R. E., Cillo, J. E., & Ulloa, J. J. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.08.003 · Cited by 720
Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia
Mavrokokki, T., Cheng, A., Stein, B., & Goss, A. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.10.061 · Cited by 650
Fournier, P. G. J., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M. C., & Clézardin, P. (2002) · PubMed · Cited by 646
Hoff, A. O., Toth, B. B., Altundag, K., Johnson, M. M., Warneke, C. L., Hu, M., Nooka, A., Sayegh, G., Guarneri, V., Desrouleaux, K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080205 · Cited by 633
Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors
Badros, A., Weikel, D., Salama, A., Goloubeva, O., Schneider, A., Rapoport, A., Fenton, R., Gahres, N., Sausville, E., Ord, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2465 · Cited by 593
Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.002 · Cited by 588
Self-citationMiller, P. D., Bolognese, M. A., Lewiecki, E. M., McClung, M. R., Ding, B., Austin, M., Liu, Y., & San Martin, J. (2008) · Bone · doi:10.1016/j.bone.2008.04.007 · Cited by 578
Morgan, G. J., Davies, F. E., Gregory, W. M., Cocks, K., Bell, S. E., Szubert, A. J., Navarro-Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62051-x · Cited by 575
Khosla, S. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.01.054 · Cited by 564
Fizazi, K., Lipton, A., Mariette, X., Body, J.-J., Rahim, Y., Gralow, J. R., Gao, G., Wu, L., Sohn, W., & Jun, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2146 · Cited by 533
Ruggiero, S. L., Fantasia, J., & Carlson, E. (2006) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2006.06.004 · Cited by 507
Self-citationRuggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Australian Endodontic Journal · doi:10.1111/j.1747-4477.2009.00213.x · Cited by 505
Self-citationBacterially induced bone destruction: mechanisms and misconceptions
Nair, S. P., Meghji, S., Wilson, M., Reddi, K., White, P., & Henderson, B. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2371-2380.1996 · Cited by 505
Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., Hutchinson, M., Lathon, P. V., Sanchez, G., Silver, P., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.050 · Cited by 493
Self-citationGnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Heck, D., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Pristauz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70122-x · Cited by 472
Kendler, D. L., Roux, C., Benhamou, C. L., Brown, J. P., Lillestol, M., Siddhanti, S., Man, H.-S., Martin, J. S., & Bone, H. G. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090716 · Cited by 453
Self-citationDimopoulos, M. A., Kastritis, E., Bamia, C., Melakopoulos, I., Gika, D., Roussou, M., Migkou, M., Eleftherakis-Papaiakovou, E., Christoulas, D., Terpos, E., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn554 · Cited by 437
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
Bone, H. G., Bolognese, M. A., Yuen, C. K., Kendler, D. L., Wang, H., Liu, Y., & San Martin, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2814 · Cited by 425
Self-citationBreast-Cancer Adjuvant Therapy with Zoledronic Acid
Coleman, R. E., Marshall, H., Cameron, D., Dodwell, D., Burkinshaw, R., Keane, M., Gil, M., Houston, S. J., Grieve, R. J., Barrett-Lee, P. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105195 · Cited by 424
Breast-cancer Adjuvant Therapy With Zoledronic Acid
Coleman, R. E., Marshall, H. C., Cameron, D., et al. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 413
Ripamonti, C. I., Maniezzo, M., Campa, T., Fagnoni, E., Brunelli, C., Saibene, G., Bareggi, C., Ascani, L., & Cislaghi, E. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn526 · Cited by 405
Hansen, T., Kunkel, M., Weber, A., & James Kirkpatrick, C. (2006) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2006.00391.x · Cited by 368
Hellstein, J. W., Adler, R. A., Edwards, B., Jacobsen, P. L., Kalmar, J. R., Koka, S., Migliorati, C. A., & Ristic, H. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0108 · Cited by 363
Fracture risk and zoledronic acid therapy in men with osteoporosis
Boonen, S., Reginster, J.-Y., Kaufman, J.-M., Lippuner, K., Zanchetta, J., Langdahl, B., Rizzoli, R., Lipschitz, S., Dimai, H. P., Witvrouw, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204061 · Cited by 359
Santini, D., Vincenzi, B., Dicuonzo, G., Avvisati, G., Massacesi, C., Battistoni, F., Gavasci, M., Rocci, L., Tirindelli, M. C., Altomare, V., et al. (2003) · PubMed · Cited by 350
Papapoulos, S., Chapurlat, R., Libanati, C., Brandi, M. L., Brown, J. P., Czerwiński, E., Krieg, M.-A., Man, Z., Mellström, D., Radominski, S. C., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1479 · Cited by 344
Self-citationDimopoulos, M. A., Kastritis, E., Anagnostopoulos, A., Melakopoulos, I., Gika, D., Moulopoulos, L. A., Bamia, C., Terpos, E., Tsionos, K., & Bamias, A. (2006) · PubMed · Cited by 340
Scagliotti, G. V., Hirsh, V., Siena, S., Henry, D. H., Woll, P. J., Manegold, C., Solal-Celigny, P., Rodriguez, G., Krzakowski, M., Mehta, N. D., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aec2b · Cited by 335
Lewiecki, E. M., Miller, P. D., McClung, M. R., Cohen, S. B., Bolognese, M. A., Liu, Y., Wang, A., Siddhanti, S., & Fitzpatrick, L. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070809 · Cited by 319
Zervas, K., Verrou, E., Teleioudis, Z., Vahtsevanos, K., Banti, A., Mihou, D., Krikelis, D., & Terpos, E. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06230.x · Cited by 297
Bisphosphonate Associated Osteonecrosis of the Jaw
KHAN, A. A., SÁNDOR, G. K. B., DORE, E., MORRISON, A. D., ALSAHLI, M., AMIN, F., PETERS, E., HANLEY, D. A., CHAUDRY, S. R., LENTLE, B., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080759 · Cited by 280
Self-citationBoonyapakorn, T., Schirmer, I., Reichart, P. A., Sturm, I., & Massenkeil, G. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.11.012 · Cited by 280
Osteonecrosis of the Jaw in a Patient on Denosumab
Aghaloo, T. L., Felsenfeld, A. L., & Tetradis, S. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.10.010 · Cited by 275
Self-citationTeriparatide and Osseous Regeneration in the Oral Cavity
Bashutski, J. D., Eber, R. M., Kinney, J. S., Benavides, E., Maitra, S., Braun, T. M., Giannobile, W. V., & McCauley, L. K. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005361 · Cited by 268
Self-citationBone, H. G., Chapurlat, R., Brandi, M.-L., Brown, J. P., Czerwiński, E., Krieg, M.-A., Mellström, D., Radominski, S. C., Reginster, J.-Y., Resch, H., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1597 · Cited by 254
Self-citationPeriodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat
Aghaloo, T. L., Kang, B., Sung, E. C., Shoff, M., Ronconi, M., Gotcher, J. E., Bezouglaia, O., Dry, S. M., & Tetradis, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.379 · Cited by 246
Self-citationOutcomes of Placing Dental Implants in Patients Taking Oral Bisphosphonates: A Review of 115 Cases
Grant, B.-T., Amenedo, C., Freeman, K., & Kraut, R. A. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.09.019 · Cited by 243
Sarasquete, M. E., García-Sanz, R., Marín, L., Alcoceba, M., Chillón, M. C., Balanzategui, A., Santamaria, C., Rosiñol, L., de la Rubia, J., Hernandez, M. T., et al. (2008) · Blood · doi:10.1182/blood-2008-04-147884 · Cited by 238
Christodoulou, C., Pervena, A., Klouvas, G., Galani, E., Falagas, M. E., Tsakalos, G., Visvikis, A., Nikolakopoulou, A., Acholos, V., Karapanagiotidis, G., et al. (2009) · Oncology · doi:10.1159/000201931 · Cited by 232
Maxillofacial cone beam computed tomography: essence, elements and steps to interpretation
Scarfe, W., Li, Z., Aboelmaaty, W., Scott, S., & Farman, A. (2012) · Australian Dental Journal · doi:10.1111/j.1834-7819.2011.01657.x · Cited by 232
Orwoll, E., Teglbjærg, C. S., Langdahl, B. L., Chapurlat, R., Czerwinski, E., Kendler, D. L., Reginster, J.-Y., Kivitz, A., Lewiecki, E. M., Miller, P. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1569 · Cited by 232
Self-citationOsteonecrosis of the jaws induced by anti-RANK ligand therapy
Taylor, K. H., Middlefell, L. S., & Mizen, K. D. (2010) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2009.08.030 · Cited by 228
Mandible Matrix Necrosis in Beagle Dogs After 3 Years of Daily Oral Bisphosphonate Treatment
Allen, M. R., & Burr, D. B. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.01.038 · Cited by 228
Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws
Chiandussi, S., Biasotto, M., Dore, F., Cavalli, F., Cova, M., & Di Lenarda, R. (2006) · Dentomaxillofacial Radiology · doi:10.1259/dmfr/27458726 · Cited by 224
Kikuiri, T., Kim, I., Yamaza, T., Akiyama, K., Zhang, Q., Li, Y., Chen, C., Chen, W., Wang, S., Le, A. D., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.37 · Cited by 216
Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?
Lesclous, P., Abi Najm, S., Carrel, J.-P., Baroukh, B., Lombardi, T., Willi, J.-P., Rizzoli, R., Saffar, J.-L., & Samson, J. (2009) · Bone · doi:10.1016/j.bone.2009.07.011 · Cited by 211
Risk Factors for Osteonecrosis of the Jaws: a Case-Control Study from the CONDOR Dental PBRN
Barasch, A., Cunha-Cruz, J., Curro, F. A., Hujoel, P., Sung, A. H., Vena, D., Voinea-Griffin, A. E., the CONDOR Collaborative Group, Beadnell, S., Craig, R. G., et al. (2011) · Journal of Dental Research · doi:10.1177/0022034510397196 · Cited by 211
Sonis, S. T., Watkins, B. A., Lyng, G. D., Lerman, M. A., & Anderson, K. C. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2008.04.013 · Cited by 209
Wessel, J. H., Dodson, T. B., & Zavras, A. I. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.11.032 · Cited by 208
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan, A. A., Sándor, G. K. B., Dore, E., Morrison, A. D., Alsahli, M., Amin, F., Peters, E., Hanley, D. A., CHAUDRY, S. R., Dempster, D. W., et al. (2008) · PubMed · Cited by 204
Self-citationAmadori, D., Aglietta, M., Alessi, B., Gianni, L., Ibrahim, T., Farina, G., Gaion, F., Bertoldo, F., Santini, D., Rondena, R., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70174-8 · Cited by 203
Yamazaki, T., Yamori, M., Ishizaki, T., Asai, K., Goto, K., Takahashi, K., Nakayama, T., & Bessho, K. (2012) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2012.06.020 · Cited by 193
Musto, P., Petrucci, M. T., Bringhen, S., Guglielmelli, T., Caravita, T., Bongarzoni, V., Andriani, A., D'Arena, G., Balleari, E., Pietrantuono, G., et al. (2008) · Cancer · doi:10.1002/cncr.23783 · Cited by 185
Freiberger, J. J., Padilla-Burgos, R., McGraw, T., Suliman, H. B., Kraft, K. H., Stolp, B. W., Moon, R. E., & Piantadosi, C. A. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2012.04.001 · Cited by 184
Bisphosphonate Use and the Risk of Adverse Jaw Outcomes
Cartsos, V. M., Zhu, S., & Zavras, A. I. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0016 · Cited by 183
Hokugo, A., Christensen, R., Chung, E. M., Sung, E. C., Felsenfeld, A. L., Sayre, J. W., Garrett, N., Adams, J. S., & Nishimura, I. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.23 · Cited by 183
Sedghizadeh, P. P., Kumar, S. K. S., Gorur, A., Schaudinn, C., Shuler, C. F., & Costerton, J. W. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0049 · Cited by 177
Wilde, F., Heufelder, M., Winter, K., Hendricks, J., Frerich, B., Schramm, A., & Hemprich, A. (2011) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2010.04.015 · Cited by 175
Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw
Sedghizadeh, P. P., Stanley, K., Caligiuri, M., Hofkes, S., Lowry, B., & Shuler, C. F. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0019 · Cited by 174
Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice
Bi, Y., Gao, Y., Ehirchiou, D., Cao, C., Kikuiri, T., Le, A., Shi, S., & Zhang, L. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090592 · Cited by 172
Walter, C., Al-Nawas, B., Grötz, K. A., Thomas, C., Thüroff, J. W., Zinser, V., Gamm, H., Beck, J., & Wagner, W. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.070 · Cited by 171
Potential pathophysiological mechanisms in osteonecrosis of the jaw
Landesberg, R., Woo, V., Cremers, S., Cozin, M., Marolt, D., Vunjak‐Novakovic, G., Kousteni, S., & Raghavan, S. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05835.x · Cited by 169
Jadu, F., Lee, L., Pharoah, M., Reece, D., & Wang, L. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm370 · Cited by 167
Vandone, A. M., Donadio, M., Mozzati, M., Ardine, M., Polimeni, M. A., Beatrice, S., Ciuffreda, L., & Scoletta, M. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr039 · Cited by 167
Oral Health Risk Factors for Bisphosphonate-Associated Jaw Osteonecrosis
Tsao, C., Darby, I. B., Ebeling, P. R., Walsh, K. A., O’brien-simpson, N. M., Reynolds, E. C., & Borromeo, G. L. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.02.016 · Cited by 166
Lipton, A., Steger, G. G., Figueroa, J., Alvarado, C., Solal-Celigny, P., Body, J. J., de Boer, R., Berardi, R., Gascon, P., Tonkin, K. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5234 · Cited by 162
Teriparatide Therapy for Alendronate-Associated Osteonecrosis of the Jaw
Cheung, A., & Seeman, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1002684 · Cited by 161
Self-citationHarper, R. P., & Fung, E. (2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.10.076 · Cited by 160
Estilo, C. L., Van Poznak, C. H., Wiliams, T., Bohle, G. C., Lwin, P. T., Zhou, Q., Riedel, E. R., Carlson, D. L., Schoder, H., Farooki, A., et al. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0091 · Cited by 158
Ripamonti, C. I., Cislaghi, E., Mariani, L., & Maniezzo, M. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.01.002 · Cited by 156
Montefusco, V., Gay, F., Spina, F., Miceli, R., Maniezzo, M., Ambrosini, M. T., Farina, L., Piva, S., Palumbo, A. P., Boccadoro, M., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802483778 · Cited by 154
Pautke, C., Bauer, F., Otto, S., Tischer, T., Steiner, T., Weitz, J., Kreutzer, K., Hohlweg‐Majert, B., Wolff, K., Hafner, S., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.07.014 · Cited by 151
Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws
Phal, P. M., Myall, R. W. T., Assael, L. A., & Weissman, J. L. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0518 · Cited by 149
Raje, N. S., Woo, S.-B., Hande, K., Yap, J. T., Richardson, P. G. G., Vallet, S., Treister, N. S., Hideshima, T., Sheehy, N. P., Chhetri, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1430 · Cited by 148
Vescovi, P., Manfredi, M., Merigo, E., Meleti, M., Fornaini, C., Rocca, J., & Nammour, S. (2009) · Lasers in Medical Science · doi:10.1007/s10103-009-0687-y · Cited by 141
Aguirre, J. I., Akhter, M. P., Kimmel, D. B., Pingel, J. E., Williams, A. A., Jorgensen, M., Kesavalu, L. N., & Wronski, T. J. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1669 · Cited by 141
Vescovi, P., Campisi, G., Fusco, V., Mergoni, G., Manfredi, M., Merigo, E., Solazzo, L., Gabriele, M., Gaeta, G. M., Favia, G., et al. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2010.11.007 · Cited by 140
Bedogni, A., Saia, G., Bettini, G., Tronchet, A., Totola, A., Bedogni, G., Ferronato, G., Nocini, P. F., & Blandamura, S. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.02.024 · Cited by 137
Aragon‐Ching, J. B., Ning, Y. M., Chen, C. C., Latham, L. L., Guadagnini, J.-P., Gulley, J. L., Arlen, P. M., Wright, J. J., Parnes, H. L., Figg, W. D., et al. (2009) · Cancer Investigation · doi:10.1080/07357900802208608 · Cited by 134
Grbic, J. T., Landesberg, R., Lin, S., Mesenbrink, P. G., Reid, I. R., Leung, P., Casas, N., Recknor, C. P., Hua, Y., Delmas, P. D., et al. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0017 · Cited by 134
Self-citationMozzati, M., Gallesio, G., Arata, V., Pol, R., & Scoletta, M. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2011.12.004 · Cited by 131
Periapical Disease and Bisphosphonates Induce Osteonecrosis of the Jaws in Mice
Kang, B., Cheong, S., Chaichanasakul, T., Bezouglaia, O., Atti, E., Dry, S., Pirih, F. Q. M., Aghaloo, T. L., & Tetradis, S. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1894 · Cited by 130
Self-citationThumbigere‐Math, V., Tu, L. S., Huckabay, S., Dudek, A. Z., Lunos, S. A., Basi, D. L., Hughes, P. J., Leach, J. W., Swenson, K. K., & Gopalakrishnan, R. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182155fcb · Cited by 129
Zoledronic Acid-Related Angiogenesis Modifications and Survival in Advanced Breast Cancer Patients
Vincenzi, B., Santini, D., Dicuonzo, G., Battistoni, F., Gavasci, M., Cesa, A. L., Grilli, C., Virzì, V., Gasparro, S., Rocci, L., et al. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.144 · Cited by 129
Vescovi, P., Merigo, E., Meleti, M., Manfredi, M., Guidotti, R., & Nammour, S. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01091.x · Cited by 128
Sharma, D., Ivanovski, S., SLEVIN, M. A., Hamlet, S. M., Pop, T. S., Brînzaniuc, K., Petcu, E. B., & Miroiu, R. I. (2013) · Vascular Cell · doi:10.1186/2045-824x-5-1 · Cited by 128
Barrett-Lee, P. J., Casbard, A. C., Abraham, J., Hood, K., Coleman, R. E., Simmonds, P., Timmins, H., Wheatley, D. A., Grieve, R., Griffiths, G. O., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70539-4 · Cited by 128
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients
Bisdas, S., Chambron-Pinho, N., Smolarz, A., Sader, R. A., Vogl, T. J., & Mack, M. G. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.04.023 · Cited by 128
The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
Grbic, J. T., Black, D. M., Lyles, K. W., Reid, D. M., ORWOLL, E. S., McClung, M. R., Bucci-Rechtweg, C. M., & Su, G. (2010) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2010.0082 · Cited by 126
Antiresorptives and Osteonecrosis of the Jaw
Yamashita, J., & McCauley, L. K. (2012) · Journal of Evidence Based Dental Practice · doi:10.1016/s1532-3382(12)70046-5 · Cited by 123
Self-citationColeman, R. E., Woodward, E., Brown, J. E., Cameron, D., Bell, R., Dodwell, D. J., Keane, M., Gil, M., Davies, C., Burkinshaw, R., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1429-y · Cited by 120
Self-citationBisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts
Ravosa, M. J., Ning, J., Liu, Y., & Stack, M. S. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.11.003 · Cited by 119
Brunello, A., Saia, G., Bedogni, A., Scaglione, D., & Basso, U. (2008) · Bone · doi:10.1016/j.bone.2008.08.132 · Cited by 118
McClung, M. R., Miller, P. D., Recknor, C. P., Mesenbrink, P. G., Bucci-Rechtweg, C. M., & Benhamou, C.-L. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181bdce0a · Cited by 117
Gimsing, P., Carlson, K. E., Turesson, I., Fayers, P. M., Waage, A., Vangsted, A. J., Mylin, A. K., Gluud, C. N., Juliusson, G., Gregersen, H., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70198-4 · Cited by 117
Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis
Peddi, P., Lopez-Olivo, M. A., Pratt, G. F., & Suarez-Almazor, M. E. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.002 · Cited by 117
Fehm, T. N., Beck, V., Banys-Paluchowski, M. J., Lipp, H., Hairass, M., Reinert, S., Solomayer, E., Wallwiener, D. R., & Krimmel, M. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.11.029 · Cited by 116
Corso, A., Varettoni, M., Zappasodi, P., Klersy, C., Mangiacavalli, S., Pica, G.-M., & Lazzarino, M. (2007) · Leukemia · doi:10.1038/sj.leu.2404682 · Cited by 115
Lodi, G., Sardella, A., Salis, A., Demarosi, F., Tarozzi, M., & Carrassi, A. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.07.068 · Cited by 115
Genomewide Pharmacogenetics of Bisphosphonate-Induced Osteonecrosis of the Jaw: The Role of RBMS3
Nicoletti, P., Cartsos, V. M., Palaska, P. K., Shen, Y., Floratos, A., & Zavras, A. I. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0202 · Cited by 115
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients
Wass, J. A. H. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.07.016 · Cited by 114
Effect of Zoledronate on Oral Wound Healing in Rats
Yamashita, J., Koi, K., Yang, D.-Y., & McCauley, L. K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1614 · Cited by 114
Self-citationKatz, J., Gong, Y., Salmasinia, D., Hou, W., Burkley, B., Ferreira, P., Casanova, O. B., Langaee, T. Y., & Moreb, J. S. (2011) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2011.02.002 · Cited by 111
Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
Atalay, B., Yalçın, S., Emes, Y., Aktaş, İ., Aybar, B., İşsever, H., Mandel, N. M., Çetin, Ö., & Öncü, B. (2011) · Lasers in Medical Science · doi:10.1007/s10103-011-0974-2 · Cited by 110
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients
Hoff, A. O., Toth, B., Hu, M. I.-N., Hortobágyi, G. N., & Gagel, R. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05771.x · Cited by 105
Bisphosphonate‐associated osteonecrosis of the auditory canal
Polizzotto, M. N., Cousins, V., & Schwarer, A. P. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05833.x · Cited by 104
RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With Periapical Disease
Aghaloo, T. L., Cheong, S., Bezouglaia, O., Kostenuik, P. J., Atti, E., Dry, S., Pirih, F. Q. M., & Tetradis, S. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2097 · Cited by 103
Self-citationBisphosphonate-related Osteonecrosis of the Jaw: A Pictorial Review
Morag, Y., Morag-Hezroni, M., Jamadar, D. A., Ward, B. B., Jacobson, J. A., Zwetchkenbaum, S. R., & Helman, J. I. (2009) · Radiographics · doi:10.1148/rg.297095050 · Cited by 98
Mauri, D., Valachis, A., Polyzos, I. P., Polyzos, N. P., Kamposioras, K. V., & Pesce, L. L. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0432-z · Cited by 92
Denosumab-related osteonecrosis of the jaw
Dios, P. D., López-Cedrún, J. L., Arenaz, J., & Scully, C. M. (2012) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2012.0323 · Cited by 92
Pozzi, S., Marcheselli, R., Sacchi, S., Baldini, L., Angrilli, F., Pennese, E., Quarta, G., Stelitano, C. C., Caparrotti, G., Luminari, S., et al. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600977690 · Cited by 92
Sebastián, J. V. B., Jiménez, Y., Gómez, D., Sirera, R., Poveda, R., & Scully, C. M. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.01.012 · Cited by 90
Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma
Orita, Y., Sugitani, I., Toda, K., Manabe, J., & Fujimoto, Y. (2010) · Thyroid · doi:10.1089/thy.2010.0169 · Cited by 89
疋田, 久., Miyazawa, K., Tabuchi, M., Kimura, M., & Goto, S. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0090-6 · Cited by 89
Bonacina, R. M., Mariani, U., Villa, F., & Villa, A. (2011) · PubMed · Cited by 88
Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model
Pautke, C., Kreutzer, K., Weitz, J., Knoedler, M., Münzel, D., Wexel, G., Otto, S., Hapfelmeier, A., Stürzenbaum, S. R., & Tischer, T. (2012) · Bone · doi:10.1016/j.bone.2012.04.020 · Cited by 87
Kwon, Y., Kim, D., Ohe, J., Yoo, J.-Y., & Walter, C. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.04.067 · Cited by 87
Subramanian, G., Cohen, H. V., & Quek, S. Y. P. (2011) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2011.04.020 · Cited by 87
Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw.
Troeltzsch, M., Woodlock, T. J., Kriegelstein, S., Steiner, T., Meßlinger, K., & Troeltzsch, M. (2012) · PubMed · Cited by 87
Schubert, M., Klatte, I., Linek, W., Müller, B., Döring, K., Eckelt, U., Hemprich, A., Berger, U., & Hendricks, J. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.11.004 · Cited by 86
Zavras, A. I., & Zhu, S. (2006) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.02.011 · Cited by 85
Lee, J., Cheng, S., Jeng, J., Chiang, C., Lau, H., & Kok, S. (2010) · Head & Neck · doi:10.1002/hed.21380 · Cited by 84
Chang, S. T., Tenforde, A. S., Grimsrud, C. D., O’Ryan, F., Gonzalez, J. R., Baer, D. M., Chandra, M., & Lo, J. C.-M. (2012) · Bone · doi:10.1016/j.bone.2012.05.010 · Cited by 84
Self-citationHines, S. L., Mincey, B. A., Dentchev, T., Sloan, J. A., Perez, E. A., Johnson, D. B., Schaefer, P., Alberts, S. R., Liu, H., Kahanic, S. P., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0332-2 · Cited by 84
Incidence of bisphosphonate‐associated osteonecrosis of the jaws in breast cancer patients
Walter, C., Al‐Nawas, B., du Bois, A., Buch, L., Harter, P., & Grötz, K. A. (2009) · Cancer · doi:10.1002/cncr.24119 · Cited by 82
Khan, A. A., Rios, L. P., Sándor, G. K. B., KHAN, N., Peters, E., Rahman, M. O., Clokie, C. M. L., Dore, E., & Dubois, S. J. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100221 · Cited by 81
Self-citationMalden, N., & Lopes, V. R. (2011) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-011-0299-z · Cited by 80
Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy
Lau, A. N., & Adachi, J. D. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081176 · Cited by 80
Bisphosphonate-Induced Osteonecrosis of the Jaws, Bone Markers, and a Hypothesized Candidate Gene
Lehrer, S., Montazem, A. H., Ramanathan, L. V., Pessin, M. S., Pfail, J. L., Stock, R. G., & Kogan, R. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.09.015 · Cited by 79
Hoefert, S., & Eufinger, H. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.06.200 · Cited by 79
Narongroeknawin, P., Danila, M. I., Humphreys, L. G., Barasch, A., & Curtis, J. R. (2010) · Special Care in Dentistry · doi:10.1111/j.1754-4505.2009.00128.x · Cited by 78
Future Treatment of Bone Metastases
Lipton, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1157 · Cited by 78
The Role of Inferior Alveolar Nerve Involvement in Bisphosphonate-Related Osteonecrosis of the Jaw
Otto, S., Hafner, S., & Grötz, K. A. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.09.028 · Cited by 78
Tennis, P. S., Rothman, K. J., Bohn, R. L., Tan, H., Zavras, A. I., Laskarides, C., Calingaert, B., & Anthony, M. S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3292 · Cited by 77
Torres, S. R., Chen, C., Leroux, B. G., Lee, P., Hollender, L., & Schubert, M. M. (2011) · Dentomaxillofacial Radiology · doi:10.1259/dmfr/14636637 · Cited by 75
Bisphosphonate adverse effects, lessons from large databases
Abrahamsen, B. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833ad677 · Cited by 73
Smidt-Hansen, T., Folkmar, T. B., Fode, K., Agerbæk, M., & Donskov, F. N. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.03.019 · Cited by 73
Krishnan, A. S., Arslanoğlu, A., Yildirm, N., Silbergleit, R., & Aygün, N. (2009) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31817e4986 · Cited by 72
Berenson, J. R., Yellin, O., Boccia, R. V., Flam, M. S., Wong, S., Batuman, O., Moezi, M. M., Woytowitz, D., Duvivier, H. L., Nassir, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0666 · Cited by 72
Andriole, G. L. (2012) · Yearbook of Urology · doi:10.1016/j.yuro.2012.06.017 · Cited by 72
Osteonecrosis of the Jaw in Sweden Associated With the Oral Use of Bisphosphonate
Ulmner, M., Jarnbring, F., & Törring, O. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.06.221 · Cited by 70
Bujanda, D. A., Sarmiento, U. B., Suárez, M. Á. C., & Morales, J. A. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl408 · Cited by 69
Preventive Protocol for Tooth Extractions in Patients Treated With Zoledronate: A Case Series
Ferlito, S., Puzzo, S., & Liardo, C. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.10.055 · Cited by 68
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis
Devogelaer, J.-P., Brown, J. P., Burckhardt, P., Meunier, P. J., Goemaere, S., Lippuner, K., Body, J. J., Samsioe, G., Felsenberg, D., Fashola, T., et al. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0367-3 · Cited by 67
Self-citationUse of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study.
Etminan, M., Aminzadeh, K. K.-W., Matthew, I., & Brophy, J. M. (2008) · PubMed · Cited by 64
Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs
Allen, M. R., Kubek, D. J., Burr, D. B., Ruggiero, S. L., & Chu, T. G. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1268-4 · Cited by 63
Self-citationMoretti, F., Pelliccioni, G. A., Montebugnoli, L., & Marchetti, C. (2011) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2011.07.004 · Cited by 62
Abtahi, J., Agholme, F., Sandberg, O., & Aspenberg, P. (2012) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01125.x · Cited by 62
Tosi, P., Zamagni, E., Cangini, D., Tacchetti, P., Raimondo, F. D., Catalano, L., D’Arco, A. M., Ronconi, S., Cellini, C., Offidani, M., et al. (2006) · Blood · doi:10.1182/blood-2006-07-033571 · Cited by 62
Torres, S. R., Chen, C. S. K., Leroux, B. G., Lee, P. P., Hollender, L., Santos, E. C. A., Drew, S. P., Hung, K.-C., & Schubert, M. M. (2012) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2011.11.011 · Cited by 61
Bisphosphonates and Osteonecrosis of the Jaw: Moving from the Bedside to the Bench
Allen, M. R. (2008) · Cells Tissues Organs · doi:10.1159/000151371 · Cited by 61
Rathbone, E. J., Brown, J. E., Marshall, H. C., Collinson, M., Liversedge, V., Murden, G., Cameron, D., Bell, R. H., Spensley, S., Agrawal, R. K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.4792 · Cited by 60
Self-citationWYNGAERT, T. V. D., Wouters, K., Huizing, M. T., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-1061-0 · Cited by 59
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer
Sanna, G., Preda, L., Bruschini, R., Rocca, M. C., Ferretti, S., Adamoli, L., Verri, E., Franceschelli, L., Goldhirsch, A., & Nolè, F. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl163 · Cited by 57
Cone Beam Computed Tomography in the Diagnosis of Dental Disease
Tetradis, S., Anstey, P., & Graff‐Radford, S. B. (2010) · Journal of the California Dental Association · doi:10.1080/19424396.2010.12221763 · Cited by 56
Self-citationOsteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid
Çeti̇ner, S., Sucak, G. T., Kahraman, S., Akı, Ş. Z., Kocakahyaoğlu, B., Gültekin, S. E., Çeti̇ner, M., & Haznedar, R. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0047-9 · Cited by 55
ONJ in Two Dental Practice-Based Research Network Regions
Fellows, J. L., Rindal, D. B., Barasch, A., Gullion, C. M., Rush, W., Pihlstrom, D. J., Richman, J., The DPBRN Collaborative Group, Brooks, W. T., Carroll, J. T., et al. (2011) · Journal of Dental Research · doi:10.1177/0022034510387795 · Cited by 55
Ali-Erdem, M., Burak-Cankaya, A., Cemil-Isler, S., Demircan, S., Soluk, M., Kasapoğlu, Ç., & Oral, C. K. (2011) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.17150 · Cited by 54
An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats
López‐Jornet, P., Camacho‐Alonso, F., Molina‐Miñano, F., García, F. J., & Vicente‐Ortega, V. (2010) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2010.00927.x · Cited by 53
Pazianas, M., Blumentals, W. A., & Miller, P. D. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0502-1 · Cited by 53
Ortega, C., Montemurro, F., Faggiuolo, R., Vormola, R., Nanni, D., Goia, F., Gilardino, M. O., & Aglietta, M. (2007) · Acta Oncologica · doi:10.1080/02841860601185917 · Cited by 51
Bisphosphonates and jaw osteonecrosis: The UAMS experience
Clarke, B. M., Boyette, J. R., Vural, E. A., Suen, J. Y., Anaissie, E. J., & Stack, B. C. (2007) · Otolaryngology · doi:10.1016/j.otohns.2006.11.008 · Cited by 51
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris
Maurer, P., Sandulescu, T., Kriwalsky, M. S., Rashad, A., Hollstein, S., Stricker, I., Hölzle, F., & Kunkel, M. (2010) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2010.11.006 · Cited by 50
Sieber, P., Lardelli, P., Kraenzlin, C. A., Kraenzlin, M. E., & Meier, C. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-012-0041-1 · Cited by 49
Sedghizadeh, P. P., Yooseph, S., Fadrosh, D. W., Allen, L. Z., Thiagarajan, M., Salek, H., Farahnik, F., & Williamson, S. J. (2012) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2012.08.444 · Cited by 49
The progress of the periodontal syndrome in the rice rat
Gotcher, J. E., & Jee, W. S. S. (1981) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1981.tb00995.x · Cited by 49
Assaf, A. T., Smeets, R., Riecke, B., Weise, E., Gröbe, A., Blessmann, M., Steiner, T., Wikner, J., Friedrich, R. E., Heiland, M., et al. (2013) · PubMed · Cited by 48
Cafro, A. M., Barbarano, L., Nosari, A., D’Avanzo, G., Nichelatti, M., Bibas, M., Gaglioti, D., Taroni, A., Riva, F. M. G., D’Avanzo, G., et al. (2008) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2008.n.013 · Cited by 48
Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model
Abtahi, J., Agholme, F., & Aspenberg, P. (2013) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2013.02.007 · Cited by 47
Sissung, English, B. C., Baum, Adelberg, Sissung, Kluetz, Dahut, Price, & Figg (2010) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s14303 · Cited by 45
Experimental development of bisphosphonate‐related osteonecrosis of the jaws in rodents
Neto, N. C., Spolidório, L. C., de Andrade, C. R., Bastos, A. D. S., Guimarães, M. R., & Marcantônio, É. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12007 · Cited by 45
The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches
Soki, F. N., Li, X., Berry, J. E., Koh, A. J., Sinder, B. P., Xu, Q., Kozloff, K. M., Taichman, R. S., & McCauley, L. K. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24301 · Cited by 42
Self-citationYamazaki, T., Yamori, M., Yamamoto, K., Saito, K., Asai, K., Sumi, E., Goto, K., Takahashi, K., Nakayama, T., & Bessho, K. (2012) · Bone · doi:10.1016/j.bone.2012.08.115 · Cited by 40
Animal models of osteonecrosis of the jaw.
Allen, M. R. (2007) · PubMed · Cited by 37
Taylor, T., Bryant, C., & Popat, S. (2013) · BDJ · doi:10.1038/sj.bdj.2013.327 · Cited by 36
O'Connell, J. E. A., Ikeagwani, O., & Kearns, G. J. (2012) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-011-0790-5 · Cited by 35
Bonomi, M., Nortilli, R., Molino, A. M., Sava, T., Santo, A., Caldara, A., & Cetto, G. (2009) · Medical Oncology · doi:10.1007/s12032-009-9195-y · Cited by 35
Incidence of serious side effects with intravenous bisphosphonate: a clinical audit
Powell, D., Bowler, C., Roberts, T. E., Garton, M. J., Matthews, C., McCall, I. W., & Davie, M. W. J. (2012) · QJM · doi:10.1093/qjmed/hcs112 · Cited by 35
Oral Bisphosphonate Use Increases the Risk for Inflammatory Jaw Disease: A Cohort Study
Vestergaard, P., Schwartz, K., Rejnmark, L., Mosekilde, L., & Pinholt, E. M. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.02.093 · Cited by 34
Allen, M. R., Chu, T. G., & Ruggiero, S. L. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2012.11.016 · Cited by 33
Self-citationIn vivo effects of zoledronic acid on oral mucosal epithelial cells
Allam, E., Allen, M. R., Chu, T. G., Ghoneima, A. A. M., & Windsor, L. J. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2010.01739.x · Cited by 33
Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab
Francini, F., Pascucci, A., Francini, E., Miano, S. T., Bargagli, G., Ruggiero, G., & Petrioli, R. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0220 · Cited by 32
Allen, M. R., & Ruggiero, S. L. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.048 · Cited by 32
Self-citation
Cited by
Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
Self-citationBlack, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,712
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
Self-citationRuggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2022.02.008 · Cited by 1,141
Self-citation
Metadata
- Authors
- Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., Morgan, S. L., Obermayer-Pietsch, B., Langdahl, B. L., Al Dabagh, R., Davison, K. S., Kendler, D. L., Sándor, G. K., Josse, R. G., Bhandari, M., El Rabbany, M., Pierroz, D. D., Sulimani, R., Saunders, D. P., Brown, J. P., Compston, J., & on behalf of the International Task Force on Osteonecrosis of the Jaw
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-21
- Volume
- 30
- Issue
- 1
- Pages
- 3-23
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1957467225
- Cited by
- 1,353
- References
- 216
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.